[1]
Kader T,Hill P,Rakha EA,Campbell IG,Gorringe KL, Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape. Breast cancer research : BCR. 2018 May 2; [PubMed PMID: 29720211]
[2]
Hoogerbrugge N,Bult P,de Widt-Levert LM,Beex LV,Kiemeney LA,Ligtenberg MJ,Massuger LF,Boetes C,Manders P,Brunner HG, High prevalence of premalignant lesions in prophylactically removed breasts from women at hereditary risk for breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003 Jan 1; [PubMed PMID: 12506168]
[3]
Menes TS,Kerlikowske K,Jaffer S,Seger D,Miglioretti DL, Rates of atypical ductal hyperplasia have declined with less use of postmenopausal hormone treatment: findings from the Breast Cancer Surveillance Consortium. Cancer epidemiology, biomarkers [PubMed PMID: 19900937]
[4]
Hartmann LC,Degnim AC,Santen RJ,Dupont WD,Ghosh K, Atypical hyperplasia of the breast--risk assessment and management options. The New England journal of medicine. 2015 Jan 1; [PubMed PMID: 25551530]
[5]
Lapid O,Jolink F,Meijer SL, Pathological findings in gynecomastia: analysis of 5113 breasts. Annals of plastic surgery. 2015 Feb; [PubMed PMID: 23788148]
[6]
Peña A,Shah SS,Fazzio RT,Hoskin TL,Brahmbhatt RD,Hieken TJ,Jakub JW,Boughey JC,Visscher DW,Degnim AC, Multivariate model to identify women at low risk of cancer upgrade after a core needle biopsy diagnosis of atypical ductal hyperplasia. Breast cancer research and treatment. 2017 Jul [PubMed PMID: 28474262]
[7]
Rageth CJ,O'Flynn EA,Comstock C,Kurtz C,Kubik R,Madjar H,Lepori D,Kampmann G,Mundinger A,Baege A,Decker T,Hosch S,Tausch C,Delaloye JF,Morris E,Varga Z, First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions). Breast cancer research and treatment. 2016 Sep; [PubMed PMID: 27522516]
[8]
Allen A,Cauthen A,Dale P,Jean-Louis C,Lord A,Smith B, Evaluating the frequency of upgrade to malignancy following surgical excision of high-risk breast lesions and ductal carcinoma in situ identified by core needle biopsy. The breast journal. 2019 Jan [PubMed PMID: 30461129]
[9]
Rageth CJ,O'Flynn EAM,Pinker K,Kubik-Huch RA,Mundinger A,Decker T,Tausch C,Dammann F,Baltzer PA,Fallenberg EM,Foschini MP,Dellas S,Knauer M,Malhaire C,Sonnenschein M,Boos A,Morris E,Varga Z, Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions). Breast cancer research and treatment. 2019 Apr [PubMed PMID: 30506111]
[10]
Fisher B,Costantino JP,Wickerham DL,Cecchini RS,Cronin WM,Robidoux A,Bevers TB,Kavanah MT,Atkins JN,Margolese RG,Runowicz CD,James JM,Ford LG,Wolmark N, Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. Journal of the National Cancer Institute. 2005 Nov 16; [PubMed PMID: 16288118]
[11]
Why infertility services should be provided by family planning agencies., Atlas RS,Martinelli DD,, Journal of nurse-midwifery, 1979 Jul-Aug [PubMed PMID: 29099502]
[13]
Characteristics of applicants to nurse-midwifery educational programs., Warpinski DH,Adams CJ,, Journal of nurse-midwifery, 1979 Jul-Aug [PubMed PMID: 29146271]